Sonoma Biotherapeutics Stock

sonomabio.comHealthcareFounded: 2019Funding to Date: $335.1MM

Sonoma Biotherapeutics is a biotech company focused on the development of adoptive Treg cell therapies for autoimmune and inflammatory diseases.

Register for Details

For more details on financing and valuation for Sonoma Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Sonoma Biotherapeutics.

Register Today

Other companies like Sonoma Biotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector